These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 5471592)
21. Use of liver cytosol fractions in treatment of acute liver failure. Makowka L; Falk RE; Blendis LM; Langer B; Falk JA; Rotstein LE; Phillips MJ Surgery; 1982 Jan; 91(1):120-2. PubMed ID: 7054900 [No Abstract] [Full Text] [Related]
22. [Clinical trial of liver-protective agents containing cytidine and uridine in the therapy of patients with liver diseases]. Grimaldi N; Santoro C Policlinico Med; 1971; 78(3):134-46. PubMed ID: 5568445 [No Abstract] [Full Text] [Related]
23. [On the treatment of various liver diseases by oral administration of arginine glucose-1-phosphate]. Arrigo A Clin Ter; 1967 Dec; 43(6):523-41. PubMed ID: 5617980 [No Abstract] [Full Text] [Related]
24. [On the so-called hepatoprotective drugs. II. The so-called hepatoprotective drugs in the treatment of liver diseases]. Mauro V Clin Ter; 1967 May; 41(3):265-86. PubMed ID: 4177978 [No Abstract] [Full Text] [Related]
25. [Considerations on the treatment with the combination of ribonucleosides, hepatic extract and vitamin B-12 (Nuclepatox) of acute and chronic liver diseases in the course of pulmonary tuberculosis]. Ravazzoni C; Balzano E; Cuneo S Minerva Med; 1967 Jan; 58(6):141-7. PubMed ID: 6016918 [No Abstract] [Full Text] [Related]
26. [Experiences with a liver preparation containing digestive enzymes. (Preliminary report)]. Bannaski H ZFA (Stuttgart); 1978 Nov; 54(32):1685-6. PubMed ID: 735325 [No Abstract] [Full Text] [Related]
28. [Clinical trial of the intravenous administration of a combination of amino acids and of an antitoxic liver extract]. Malvicini G; Tinozzi S Minerva Med; 1968 Mar; 59(19):1027-33. PubMed ID: 5646216 [No Abstract] [Full Text] [Related]
29. [On the problem of effects and side effects of steroids and liver hydrolysates in acute and chronic liver diseases]. Kleine FD Z Arztl Fortbild (Jena); 1966 Aug; 60(15):900-4. PubMed ID: 5995281 [No Abstract] [Full Text] [Related]
30. [On 30 cases of moderate hepatic insufficiency treated with the combination of diisopropylammonium dichloroethanoate, antitoxic hepatic extract and B complex]. Gambini G; Manganaro M Arch Ital Sci Med Trop Parassitol; 1965; 46(9):359-62. PubMed ID: 5853821 [No Abstract] [Full Text] [Related]
31. [The behavior of the sulfobromophthalein chromoelimination curves subjects with ethylic hepatopathy treated with a liver extract enriched with nucleosides of the pyrimidine series and ith cyanocobalamine]. D'Agostino F Minerva Med; 1970 Oct; 61(87):4893-901. PubMed ID: 5488540 [No Abstract] [Full Text] [Related]
32. Studies on the prevention and cure of experimentally induced functional and morphological liver changes. Neukomm S; Kiraly M Arzneimittelforschung; 1967 Sep; 17(9):1135-42. PubMed ID: 5632288 [No Abstract] [Full Text] [Related]
33. [Evaluation of therapeutic activity of a new pharmacologic combination in patients with chronic liver and debilitating diseases]. Pasotti C; Buniva G; Carpinella G Clin Ter; 1971 Mar; 56(5):427-39. PubMed ID: 5564990 [No Abstract] [Full Text] [Related]
34. [Hepa-listrocol in the therapy of chronic inflammatory liver diseases]. Baum HH Landarzt; 1967 Apr; 43(11):530-3. PubMed ID: 5585071 [No Abstract] [Full Text] [Related]
35. [The effect of a new hepatoprotective drug on bilirubinemia in geriatric age patients]. Baldoni E; Floris E; Nuzzo L G Gerontol; 1968 Aug; 16(8):789-92. PubMed ID: 5740954 [No Abstract] [Full Text] [Related]
36. [Hepatotropic and proteo-anabolic therapeutic effects of a total hepatic preparation with a constant titer of natural coenzymatic cobalamin]. Guidetti E; Vacha R; Vacha G Clin Ter; 1969 May; 49(4):323-36. PubMed ID: 5795020 [No Abstract] [Full Text] [Related]